Research Article
Serum Levels of Matrix Metalloproteinase-1 in Brazilian Patients with Benign Prostatic Hyperplasia or Prostate Cancer
Table 1
Clinical data of individuals diagnosed with PCa or BPH.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BMI: body mass index; BPH: benign prostatic hyperplasia; GT: gamma-glutamyl transferase; HbA1c: glycated hemoglobin type-A1c; HDL: high-density lipoprotein; HOMA: homeostasis model assessment; LDL: low-density lipoprotein; PCa: prostate cancer; PSA: prostate-specific antigen; SGOT: serum glutamic-oxaloacetic transaminase; SGPT: serum glutamic-pyruvic transaminase; TC: total cholesterol; TGL: triglycerides; TSH: thyroid stimulating hormone; VLDL: very low-density lipoprotein. Data are expressed within each group as mean ± standard deviation or median with interquartile intervals in brackets. values for comparison of differences are calculated using Student's t-test, exception is for the use of the Mann–Whitney test† for nonparametric data. |